Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

BCR-ABL1 doubling times more reliably assess the dynamics of CML relapse compared with the BCR-ABL1 fold rise: implications for monitoring and management

Blood (2012) 119 (18): 4264–4271.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals